Correlation Between Arcus Biosciences and Structure Therapeutics
Can any of the company-specific risk be diversified away by investing in both Arcus Biosciences and Structure Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Arcus Biosciences and Structure Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Arcus Biosciences and Structure Therapeutics American, you can compare the effects of market volatilities on Arcus Biosciences and Structure Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Arcus Biosciences with a short position of Structure Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Arcus Biosciences and Structure Therapeutics.
Diversification Opportunities for Arcus Biosciences and Structure Therapeutics
-0.41 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Arcus and Structure is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding Arcus Biosciences and Structure Therapeutics America in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Structure Therapeutics and Arcus Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Arcus Biosciences are associated (or correlated) with Structure Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Structure Therapeutics has no effect on the direction of Arcus Biosciences i.e., Arcus Biosciences and Structure Therapeutics go up and down completely randomly.
Pair Corralation between Arcus Biosciences and Structure Therapeutics
Given the investment horizon of 90 days Arcus Biosciences is expected to generate 1.23 times more return on investment than Structure Therapeutics. However, Arcus Biosciences is 1.23 times more volatile than Structure Therapeutics American. It trades about 0.09 of its potential returns per unit of risk. Structure Therapeutics American is currently generating about -0.12 per unit of risk. If you would invest 825.00 in Arcus Biosciences on April 26, 2025 and sell it today you would earn a total of 162.00 from holding Arcus Biosciences or generate 19.64% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Arcus Biosciences vs. Structure Therapeutics America
Performance |
Timeline |
Arcus Biosciences |
Structure Therapeutics |
Arcus Biosciences and Structure Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Arcus Biosciences and Structure Therapeutics
The main advantage of trading using opposite Arcus Biosciences and Structure Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Arcus Biosciences position performs unexpectedly, Structure Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Structure Therapeutics will offset losses from the drop in Structure Therapeutics' long position.Arcus Biosciences vs. Iteos Therapeutics | Arcus Biosciences vs. Annexon | Arcus Biosciences vs. Replimune Group | Arcus Biosciences vs. Mersana Therapeutics |
Structure Therapeutics vs. Terns Pharmaceuticals | Structure Therapeutics vs. Day One Biopharmaceuticals | Structure Therapeutics vs. Acumen Pharmaceuticals | Structure Therapeutics vs. Amylyx Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Complementary Tools
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data |